Platelet Glycoprotein Ibα Supports Experimental Lung Metastasis
The platelet paradigm in hemostasis and thrombosis involves an initiation step that depends on platelet membrane receptors binding to ligands on a damaged or inflamed vascular surface. Once bound to the surface, platelets provide a unique microenvironment supporting the accumulation of more platelets and the elaboration of a fibrin-rich network produced by coagulation factors. The platelet-specific receptor glycoprotein (GP) Ib-IX, is critical in this process and initiates the formation of a platelet-rich thrombus by tethering the platelet to a thrombogenic surface. A role for platelets beyond the hemostasis/thrombosis paradigm is emerging with significant platelet contributions in both tumorigenesis and inflammation. We have established congenie (N10) mouse colonies (C57BL/6J) with dysfunctional GP Ib-IX receptors in our laboratory that allow us an opportunity to examine the relevance of platelet GP Ib-IX in syngeneic mouse models of experimental metastasis. Our results demonstrate platelet GP Ib-IX contributes to experimental metastasis because a functional absence of GP Ib-IX correlates with a 15-fold reduction in the number of lung metastatic foci using B16F10.1 melanoma cells. The results demonstrate that the extracellular domain of the α-subunit of GP Ib is the structurally relevant component of the GP Ib-IX complex contributing to metastasis. Our results support the hypothesis that platelet GP Ib-IX functions that support normal hemostasis or pathologic thrombosis also contribute to tumor malignancy..
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2007 |
---|---|
Erschienen: |
2007 |
Enthalten in: |
Zur Gesamtaufnahme - volume:104 |
---|
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Jain, Shashank [VerfasserIn] |
---|
Links: |
---|
Themen: |
Adhesion |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
JST06945339X |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | JST06945339X | ||
003 | DE-627 | ||
005 | 20240116233846.0 | ||
007 | cr uuu---uuuuu | ||
008 | 150325s2007 xx |||||o 00| ||eng c | ||
035 | |a (DE-627)JST06945339X | ||
035 | |a (JST)25427792 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Jain, Shashank |e verfasserin |4 aut | |
245 | 1 | 0 | |a Platelet Glycoprotein Ibα Supports Experimental Lung Metastasis |
264 | 1 | |c 2007 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
520 | |a The platelet paradigm in hemostasis and thrombosis involves an initiation step that depends on platelet membrane receptors binding to ligands on a damaged or inflamed vascular surface. Once bound to the surface, platelets provide a unique microenvironment supporting the accumulation of more platelets and the elaboration of a fibrin-rich network produced by coagulation factors. The platelet-specific receptor glycoprotein (GP) Ib-IX, is critical in this process and initiates the formation of a platelet-rich thrombus by tethering the platelet to a thrombogenic surface. A role for platelets beyond the hemostasis/thrombosis paradigm is emerging with significant platelet contributions in both tumorigenesis and inflammation. We have established congenie (N10) mouse colonies (C57BL/6J) with dysfunctional GP Ib-IX receptors in our laboratory that allow us an opportunity to examine the relevance of platelet GP Ib-IX in syngeneic mouse models of experimental metastasis. Our results demonstrate platelet GP Ib-IX contributes to experimental metastasis because a functional absence of GP Ib-IX correlates with a 15-fold reduction in the number of lung metastatic foci using B16F10.1 melanoma cells. The results demonstrate that the extracellular domain of the α-subunit of GP Ib is the structurally relevant component of the GP Ib-IX complex contributing to metastasis. Our results support the hypothesis that platelet GP Ib-IX functions that support normal hemostasis or pathologic thrombosis also contribute to tumor malignancy. | ||
540 | |a Copyright 2007 The National Academy of Sciences of the United States of America | ||
650 | 4 | |a Adhesion | |
650 | 4 | |a Tumor | |
650 | 4 | |a Hemostasis | |
650 | 4 | |a Knockout | |
650 | 4 | |a Melanoma | |
650 | 4 | |a Biological sciences |x Biology |x Physiology |x Body composition |x Body fluids |x Blood |x Blood cells |x Platelets | |
650 | 4 | |a Health sciences |x Medical conditions |x Diseases |x Neoplasia |x Tumors | |
650 | 4 | |a Health sciences |x Medical conditions |x Diseases |x Neoplasia |x Cancer |x Metastasis | |
650 | 4 | |a Health sciences |x Health care industry |x Medical practice |x General practice | |
650 | 4 | |a Biological sciences |x Biology |x Zoology |x Animals |x Mammals |x Rodents |x Mice | |
650 | 4 | |a Biological sciences |x Biology |x Physiology |x Body composition |x Body fluids |x Blood | |
650 | 4 | |a Physical sciences |x Chemistry |x Chemical compounds |x Chemicals |x Polymers |x Biopolymers |x Proteins |x Receptors | |
650 | 4 | |a Health sciences |x Medical conditions |x Diseases |x Hematologic diseases |x Thrombosis | |
650 | 4 | |a Biological sciences |x Biology |x Physiology |x System physiology |x Cardiovascular physiology |x Blood circulation |x Hemostasis | |
650 | 4 | |a Mathematics |x Applied mathematics |x Statistics |x Applied statistics |x Descriptive statistics |x Central tendencies |x Statistical median | |
650 | 4 | |a Biological sciences |x Biology |x Physiology |x Body composition |x Body fluids |x Blood |x Blood cells |x Platelets | |
650 | 4 | |a Health sciences |x Medical conditions |x Diseases |x Neoplasia |x Tumors | |
650 | 4 | |a Health sciences |x Medical conditions |x Diseases |x Neoplasia |x Cancer |x Metastasis | |
650 | 4 | |a Health sciences |x Health care industry |x Medical practice |x General practice | |
650 | 4 | |a Biological sciences |x Biology |x Zoology |x Animals |x Mammals |x Rodents |x Mice | |
650 | 4 | |a Biological sciences |x Biology |x Physiology |x Body composition |x Body fluids |x Blood | |
650 | 4 | |a Physical sciences |x Chemistry |x Chemical compounds |x Chemicals |x Polymers |x Biopolymers |x Proteins |x Receptors | |
650 | 4 | |a Health sciences |x Medical conditions |x Diseases |x Hematologic diseases |x Thrombosis | |
650 | 4 | |a Biological sciences |x Biology |x Physiology |x System physiology |x Cardiovascular physiology |x Blood circulation |x Hemostasis | |
650 | 4 | |a Mathematics |x Applied mathematics |x Statistics |x Applied statistics |x Descriptive statistics |x Central tendencies |x Statistical median | |
655 | 4 | |a research-article | |
700 | 1 | |a Zuka, Masahiko |e verfasserin |4 aut | |
700 | 1 | |a Liu, Jungling |e verfasserin |4 aut | |
700 | 1 | |a Russell, Susan |e verfasserin |4 aut | |
700 | 1 | |a Dent, Judith |e verfasserin |4 aut | |
700 | 1 | |a Guerrero, José A. |e verfasserin |4 aut | |
700 | 1 | |a Forsyth, Jane |e verfasserin |4 aut | |
700 | 1 | |a Maruszak, Brigid |e verfasserin |4 aut | |
700 | 1 | |a Gartner, T. Kent |e verfasserin |4 aut | |
700 | 1 | |a Felding-Habermann, Brunhilde |e verfasserin |4 aut | |
700 | 1 | |a Ware, Jerry |e verfasserin |4 aut | |
773 | 1 | 8 | |g volume:104 |g year:2007 |g number:21 |g pages:9024-9028 |
856 | 4 | 0 | |u https://www.jstor.org/stable/25427792 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_JST | ||
951 | |a AR | ||
952 | |d 104 |j 2007 |e 21 |h 9024-9028 |